Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 5Thoracic 4Gastrointestinal 2Endocrine 2Breast 2Sarcoma 1NET 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Radionuclide Imaging × Genitourinary × Clear all
NCT06904365 2026-05-18

OvAR-Y

Washington University School of Medicine

Active not recruiting
10 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Uterine Neoplasms

NCT06116253 2026-05-08

Advanced Diffusion Imaging in Renal Cancer Patients

NYU Langone Health

Phase NA Active not recruiting
39 enrolled
Genitourinary

Kidney Neoplasms

NCT06003556 2025-07-04

P-GAP

University of Alberta

Phase 2 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT05141760 2024-06-06

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

University of Alberta

Phase 2 Completed
150 enrolled
Genitourinary

Prostatic Neoplasms

NCT04000776 2023-08-28

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Université de Sherbrooke

Completed
100 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡